Cargando…
Evidence of Maternal Antibodies Elicited by COVID-19 Vaccination in Amniotic Fluid: Report of Two Cases in Italy
With SARS-CoV-2 infection, pregnant women may be at a high risk of severe disease and adverse perinatal outcomes. A COVID-19 vaccination campaign represents the key strategy to combat the pandemic; however, public acceptance of maternal immunization has to be improved, which may be achieved by highl...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321354/ https://www.ncbi.nlm.nih.gov/pubmed/35891572 http://dx.doi.org/10.3390/v14071592 |
_version_ | 1784756024661508096 |
---|---|
author | Colavita, Francesca Oliva, Alessandra Bettini, Aurora Antinori, Andrea Girardi, Enrico Castilletti, Concetta Vaia, Francesco Liuzzi, Giuseppina |
author_facet | Colavita, Francesca Oliva, Alessandra Bettini, Aurora Antinori, Andrea Girardi, Enrico Castilletti, Concetta Vaia, Francesco Liuzzi, Giuseppina |
author_sort | Colavita, Francesca |
collection | PubMed |
description | With SARS-CoV-2 infection, pregnant women may be at a high risk of severe disease and adverse perinatal outcomes. A COVID-19 vaccination campaign represents the key strategy to combat the pandemic; however, public acceptance of maternal immunization has to be improved, which may be achieved by highlighting the promising mechanism of passive immunity as a strategy for protecting newborns against SARS-CoV-2 infection. We tested the anti-SARS-CoV-2 antibody response following COVID-19 full-dose vaccination in the serum and amniotic fluid of two pregnant women who presented between April and June 2021, at the Center for the Treatment and Prevention of Infections in Pregnancy of the National Institute for Infectious Diseases “L. Spallanzani”, for antenatal consultancy. Anti-SARS-CoV-2 IgG was found in residual samples of amniotic fluid collected from both women at the 18th week of gestation (63 and 131 days after the second dose’s administration). Titers in amniotic fluid mirrored the levels detected in serum and were inversely linked to the time from vaccination. Our results suggest that antibodies elicited by COVID-19 vaccination can cross the placenta and reach the fetus; therefore, they may offer passive immunity at birth. It is critical to fully understand the kinetics of the maternal response to vaccination, the efficiency of IgG transfer, and the persistence of antibodies in infants to optimize maternal immunization regimens. |
format | Online Article Text |
id | pubmed-9321354 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-93213542022-07-27 Evidence of Maternal Antibodies Elicited by COVID-19 Vaccination in Amniotic Fluid: Report of Two Cases in Italy Colavita, Francesca Oliva, Alessandra Bettini, Aurora Antinori, Andrea Girardi, Enrico Castilletti, Concetta Vaia, Francesco Liuzzi, Giuseppina Viruses Case Report With SARS-CoV-2 infection, pregnant women may be at a high risk of severe disease and adverse perinatal outcomes. A COVID-19 vaccination campaign represents the key strategy to combat the pandemic; however, public acceptance of maternal immunization has to be improved, which may be achieved by highlighting the promising mechanism of passive immunity as a strategy for protecting newborns against SARS-CoV-2 infection. We tested the anti-SARS-CoV-2 antibody response following COVID-19 full-dose vaccination in the serum and amniotic fluid of two pregnant women who presented between April and June 2021, at the Center for the Treatment and Prevention of Infections in Pregnancy of the National Institute for Infectious Diseases “L. Spallanzani”, for antenatal consultancy. Anti-SARS-CoV-2 IgG was found in residual samples of amniotic fluid collected from both women at the 18th week of gestation (63 and 131 days after the second dose’s administration). Titers in amniotic fluid mirrored the levels detected in serum and were inversely linked to the time from vaccination. Our results suggest that antibodies elicited by COVID-19 vaccination can cross the placenta and reach the fetus; therefore, they may offer passive immunity at birth. It is critical to fully understand the kinetics of the maternal response to vaccination, the efficiency of IgG transfer, and the persistence of antibodies in infants to optimize maternal immunization regimens. MDPI 2022-07-21 /pmc/articles/PMC9321354/ /pubmed/35891572 http://dx.doi.org/10.3390/v14071592 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Case Report Colavita, Francesca Oliva, Alessandra Bettini, Aurora Antinori, Andrea Girardi, Enrico Castilletti, Concetta Vaia, Francesco Liuzzi, Giuseppina Evidence of Maternal Antibodies Elicited by COVID-19 Vaccination in Amniotic Fluid: Report of Two Cases in Italy |
title | Evidence of Maternal Antibodies Elicited by COVID-19 Vaccination in Amniotic Fluid: Report of Two Cases in Italy |
title_full | Evidence of Maternal Antibodies Elicited by COVID-19 Vaccination in Amniotic Fluid: Report of Two Cases in Italy |
title_fullStr | Evidence of Maternal Antibodies Elicited by COVID-19 Vaccination in Amniotic Fluid: Report of Two Cases in Italy |
title_full_unstemmed | Evidence of Maternal Antibodies Elicited by COVID-19 Vaccination in Amniotic Fluid: Report of Two Cases in Italy |
title_short | Evidence of Maternal Antibodies Elicited by COVID-19 Vaccination in Amniotic Fluid: Report of Two Cases in Italy |
title_sort | evidence of maternal antibodies elicited by covid-19 vaccination in amniotic fluid: report of two cases in italy |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321354/ https://www.ncbi.nlm.nih.gov/pubmed/35891572 http://dx.doi.org/10.3390/v14071592 |
work_keys_str_mv | AT colavitafrancesca evidenceofmaternalantibodieselicitedbycovid19vaccinationinamnioticfluidreportoftwocasesinitaly AT olivaalessandra evidenceofmaternalantibodieselicitedbycovid19vaccinationinamnioticfluidreportoftwocasesinitaly AT bettiniaurora evidenceofmaternalantibodieselicitedbycovid19vaccinationinamnioticfluidreportoftwocasesinitaly AT antinoriandrea evidenceofmaternalantibodieselicitedbycovid19vaccinationinamnioticfluidreportoftwocasesinitaly AT girardienrico evidenceofmaternalantibodieselicitedbycovid19vaccinationinamnioticfluidreportoftwocasesinitaly AT castilletticoncetta evidenceofmaternalantibodieselicitedbycovid19vaccinationinamnioticfluidreportoftwocasesinitaly AT vaiafrancesco evidenceofmaternalantibodieselicitedbycovid19vaccinationinamnioticfluidreportoftwocasesinitaly AT liuzzigiuseppina evidenceofmaternalantibodieselicitedbycovid19vaccinationinamnioticfluidreportoftwocasesinitaly |